Fairvalue-Calculator Fairvalue-Calculator

BlackRock Health Sciences Trust (BME) Fair Value & Analysis

Financial Services · US · Market cap $516M

Price$40.72
Fair Value$61.56
Upside+51.2%
Quality95/100
Evidence: High Range $46.17 – $76.95

Analysis

BlackRock Health Sciences Trust (BME) currently trades at $40.72, while our model-based Fair Value estimate is $61.56 — implying the stock looks roughly 51.2% undervalued today. We read business quality at 95/100 (high quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

Open the full interactive analysis →

Similar stocks

Fondul Proprietatea SA (FP) +90% The Schiehallion Fund Limited (MNTN) +100% BlackRock, Inc (UU2) -36% Blackstone Inc (BX) -56% BH Macro Limited (BHMU) +104% Investor AB (IVSBF) +100%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.